Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 501–505 of 505 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06304818	Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.	not yet recruiting	Phase 1 / Phase 2	515	Sinocelltech Ltd.INDUSTRY	0	Mar 15, 2024	clinicaltrials
NCT04165590	Plasmodium Immunotherapy for Advanced Malignant Solid Tumors	recruiting	Phase 1 / Phase 2	60	CAS Lamvac Biotech Co., Ltd.INDUSTRY	1	Feb 20, 2024	clinicaltrials